Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Phosphodiesterase inhibitors (PDEis) in the management of autoimmune disease


  • Please log in to reply
No replies to this topic

#1 GocartMoz

GocartMoz

    Silver Member

  • Members
  • PipPipPipPip
  • 164 posts
  • Location:Florida

Posted 11 March 2010 - 05:07 AM

Phosphodiesterase inhibitors (PDEis) in the management of autoimmune disease. The emerging trends make it necessary to exploit the full therapeutic potential of PDEis in various autoimmune diseases like rheumatoid arthritis, scleroderma, profibrotic conditions and PAH. (PubMed) P. Shenoy. Autoimmun Rev. February 8 2010. Also see: (SD Treatmentsand Rheumatoid Arthritis)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.